A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07522073 · RECRUITING
Trial details
- NCT number
- NCT07522073
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-09
- Primary completion
- 2028-09-15
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.